Olapar is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
#Olanib #Olaparib150mg #IebPharma #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/olanib-150-mg-olaparib
#Olanib #Olaparib150mg #IebPharma #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/olanib-150-mg-olaparib
Olapar is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
#Olanib #Olaparib150mg #IebPharma #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/olanib-150-mg-olaparib
0 Commentarii
0 Distribuiri
12 Views
0 previzualizare